Strategic partnerships All G has active and upcoming collaborations with Armor Protéines to scale lactoferrin production and commercialisation, signaling a clear route-to-market through joint ventures that can be leveraged for co-selling opportunities and expanded distribution.

New product launches Recent launch of cow-free lactoferrin in the US and a planned human-identical protein rollout indicate strong interest from infant nutrition players and specialty dairy brands, presenting a channel to pursue license, ODM, or co-development deals with formulators and manufacturers.

Supply chain potential A joint venture and licensing signals with an established producer base create scalable supply capacity for precision fermentation proteins, enabling outreach to manufacturers seeking high-value milk proteins for premium powders, beverages, and supplements.

Public funding traction Multiple government grants and a broader funding round activity demonstrate risk-sharing support and validation, which can be used to engage with investors and potential co-funders in tiered financing or grant-backed pilot programs with target customers.

Technical differentiation Focus on cow-free and human-identical lactoferrin positions All G as a supplier of high-value, clinically relevant proteins for infant nutrition and specialty dairy, making it a compelling partner for R&D collaborations, pilot programs, and custom protein formulation with formulators and biotech manufacturers.